Your browser doesn't support javascript.
loading
The effect of intravenous unit-dose tranexamic acid on visible and hidden blood loss in posterior lumbar interbody fusion: a randomized clinical trial.
Hao, Shenshen; Li, Hongke; Liu, Shuai; Meng, Saike; Zhang, Xiaopeng; Wang, Linfei; Yang, Hongjie; Zhang, Liyan; Dong, Shengli.
Afiliación
  • Hao S; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Li H; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Liu S; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Meng S; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Zhang X; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Wang L; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Yang H; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Zhang L; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China.
  • Dong S; Department of Spine and Bone Oncology, General Hospital of Pingmei Shenma Medical Group, Pingdingshan, 467000, Henan, China. dong0375@126.com.
Sci Rep ; 13(1): 4714, 2023 03 22.
Article en En | MEDLINE | ID: mdl-36949108

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Tranexámico / Hemostáticos / Antifibrinolíticos Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Tranexámico / Hemostáticos / Antifibrinolíticos Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido